Mind Cure Health Is Shutting Down All Operations, Citing Lack Of Funds To Move Forward
Mind Cure Health Is Shutting Down All Operations, Citing Lack Of Funds To Move Forward
Mind Cure Health Inc. (CSE:MCUR) (OTCQX:MCURF) (FRA: 6MH), a mental health and wellness company working in the psychedelics sector, announced that a special committee its board of directors concluded a review process and has determined that the capital required to continue the Company's business plan is unlikely to be found under the current and foreseeable market conditions.
Mind Cure Health Inc。(CSE：MCUR)(OTCQX：MCURF)(FRA：6MH)是一家從事迷幻藥物領域的精神健康和健康公司，該公司宣佈，其董事會成立了一個特別委員會，審查過程中，並已確定，在當前和可預見的市場條件下，不太可能找到繼續本公司業務計劃所需的資本。
Shutting Down
正在關閉
As such, the Board decided to immediately eliminate all expenditures outside those required to preserve the value of the Company's assets and will immediately cut all of its C-suite executives and employees, except for its CFO, vice president of engineering and certain administrative staff required to wind-down the its operations.
因此，董事會決定 立即取消公司資產保值所需支出以外的所有支出該公司將立即裁減所有高管和員工，但首席財務官、工程副總裁和某些需要逐步結束業務的行政人員除外。
"Though we continue the Strategic Review Process, we have identified no available strategic alternatives that would require further development and execution of MINDCURE's existing business plan," said the chair of MINDCURE's Special Committee, Jason Pamer.
MINDCURE特別委員會主席表示：“儘管我們繼續進行戰略審查進程，但我們沒有發現需要進一步制定和執行MINDCURE現有業務計劃的可用戰略選擇。”傑森·帕默.
The Company will also stop all non-committed expenditures related to the development and marketing work of its iSTRYM product, R&D related to its synthetic ibogaine program and R&D related to its Desire Project.
公司也將停止所有與其iSTRYM產品的開發和營銷工作有關的未承諾支出，與其合成ibogaine計劃有關的研發，以及與其Desire Project有關的研發。
"While we truly appreciate the impact of these changes on our team and our suppliers, our Strategic Review Process has led us to believe that the actions announced in this news release are necessary to preserve cash position and maintain value of the Company's other assets while the Company continues to seek a strategic transaction," said Philip Tapley, chair of MINDCURE's board of directors and interim CEO.
雖然我們真正理解這些變化對我們的團隊和我們的供應商的影響，但我們的戰略審查過程使我們相信，在公司繼續尋求戰略交易的同時，本新聞稿中宣佈的行動對於保持公司的現金狀況和其他資產的價值是必要的。菲利普·塔普利MINDCURE董事會主席兼臨時首席執行官。
Other than what was described in a company press release, Mind Cure has not announced any decisions related to strategic alternatives or expressed assurances regarding the evaluation of strategic alternatives.
與公司新聞稿中所描述的不同，Mind Cure尚未宣佈任何與戰略選擇有關的決定，也沒有就戰略選擇的評估表示保證。
"The Company does not intend to comment further unless and until further disclosure is appropriate or necessary," according the release.
根據新聞稿，公司不打算進一步置評，除非進一步披露是適當的或有必要的。
Mind Cure's stock stopped trading when the news was announced but did resume after a few hours and then fell by 38%.
消息公佈後，Mind Cure的股票停止交易，但幾個小時後確實恢復了交易，隨後下跌了38%。